Psychoactive substances with chemical structures or pharmacological profiles that are
similar to traditional drugs of abuse continue to emerge on the recreational drug market …

Dysregulation of the endogenous lipid mediators endocannabinoids and their G-protein-
coupled cannabinoid receptors 1 and 2 (CB1R and CB2R) has been implicated in a variety …

Background Synthetic cannabinoids (SC) are a heterogeneous group of compounds
developed to probe the endogenous cannabinoid system or as potential therapeutics …

Abstract Context: Synthetic cannabinoids (SCs) such as “Spice”,“K2”, etc. are widely
available via the internet despite increasing legal restrictions. Currently, the prevalence of …

The word “cannabinoid” refers to every chemical substance, regardless of structure or origin,
that joins the cannabinoid receptors of the body and brain and that have similar effects to …

Novel psychoactive substances include synthetic cannabinoids, cathinone derivatives,
psychedelic phenethylamines, novel stimulants, synthetic opioids, tryptamine derivatives …

Synthetic cannabinoids (SCBs), also known under the brand names of “Spice,”“K2,”“herbal
incense,”“Cloud 9,”“Mojo” and many others, are becoming a large public health concern due …

K2 or Spice products are emerging drugs of abuse that contain synthetic cannabinoids
(SCBs). Although assumed by many teens and first time drug users to be a “safe” and “legal” …

Cannabis use is associated with an increased risk of psychosis in vulnerable individuals.
Cannabis containing high levels of the partial cannabinoid receptor subtype 1 (CB1) agonist …

A number of N-alkyl indole or indazole-3-carbonyl analogs, with modified chemical
structures, are distributed throughout the world as synthetic cannabinoids. Like synthetic …